Neomorph, Inc., a venture backed biotechnology company solving critical problems in human health through the discovery and development of innovative new medicines against ‘undruggable targets,’ announced the appointment of Bell Zhong as the company’s Chief Financial Officer.
September 7, 2022
· 3 min read
